Providers or prospective providers must draw up a real-world testing plan and submit it to the market surveillance authority.
(a)
the provider or prospective provider has drawn up a real-world testing plan and submitted it to the market surveillance authority in the Member State where the testing in real world conditions is to be conducted;
Providers or prospective providers must register the testing in real world conditions with a Union-wide unique single identification number and with the information specified in Annex IX.
(c)
the provider or prospective provider, with the exception of providers or prospective providers of high-risk AI systems referred to in points 1, 6 and 7 of Annex III in the areas of law enforcement, migration, asylum and border control management, and high-risk AI systems referred to in point 2 of Annex III has registered the testing in real world conditions in accordance with Article 71(4) with a Union-wide unique single identification number and with the information specified in Annex IX
Market surveillance authority must approve the testing in real world conditions and the real-world testing plan.
(b)
the market surveillance authority in the Member State where the testing in real world conditions is to be conducted has approved the testing in real world conditions and the real-world testing plan;
Providers or prospective providers must ensure that data collected and processed for the purpose of the testing in real world conditions is transferred to third countries only provided that appropriate and applicable safeguards under Union law are implemented.
(e)
data collected and processed for the purpose of the testing in real world conditions shall be transferred to third countries only provided that appropriate and applicable safeguards under Union law are implemented;
Get notified when new obligations, deadlines, or guidance are added — or ask us how the caveauAI Compliance Workbench can track this for your organization.